Stereotactic injection of AAV-miR-129-5p attenuated microglia activation in depressed mice. حسب Qiaozhen Qin (13159201)

الموضوعات:

Stereotactic injection of AAV-miR-129-5p suppressed astrocyte activation in depressed mice. حسب Qiaozhen Qin (13159201)

الموضوعات:

Relationship between miR-129-5p and Mysm1 in depressed mice. حسب Qiaozhen Qin (13159201)

الموضوعات:

Overexpression of miR-129-5p alleviated depression-like behaviors by increasing ATP content. حسب Qiaozhen Qin (13159201)

الموضوعات:

Overexpression of miR-129-5p alleviated the depressive-like phenotypes of CRS and LPS treated mice. حسب Qiaozhen Qin (13159201)

الموضوعات:

AZ10606120 treatment significantly increased cytotoxicity and reduced cell number in a dose-dependent manner. حسب Matthew Drill (22258391)

"…Cell numbers were significantly decreased in cells after treatment with AZ10606120 (50µM) compared to both temozolomide (TMZ; 50µM) treatment and untreated controls. …"

Rate of change in salivary amylase pre- and post-VR operation. حسب Akihiro Kakimoto (343218)

الموضوعات:

Difference in حسب Akihiro Kakimoto (343218)

الموضوعات:

Relationship between the change in حسب Akihiro Kakimoto (343218)

الموضوعات:

Increase in multiple-choice question scores pre- and post-VR operation. حسب Akihiro Kakimoto (343218)

الموضوعات:

Multiple-choice questions and performance pre- and post-VR operation. حسب Akihiro Kakimoto (343218)

الموضوعات:

Average scores of TDMS-ST pre- and post-VR operation. حسب Akihiro Kakimoto (343218)

الموضوعات:

VR training system for radiopharmaceutical administration. حسب Akihiro Kakimoto (343218)

الموضوعات:

Experimental protocol. حسب Akihiro Kakimoto (343218)

الموضوعات:

Average scores of POMS2 pre- and post-VR operation. حسب Akihiro Kakimoto (343218)

الموضوعات:

Correlations between significantly different microbiota and metabolites. حسب Bhuripit Saraphol (20855573)

الموضوعات:

Blood Pressure and LDL-C During Follow-up. حسب Karl Ingard (22582091)

الموضوعات:

Median EQ-5D-3L index values during 5 years of follow-up. حسب Karl Ingard (22582091)

الموضوعات:

Baseline Characteristics of Included Patients. حسب Karl Ingard (22582091)

الموضوعات:

Subgroup Analysis of the Occurrence of Secondary Endpoints. حسب Karl Ingard (22582091)

الموضوعات: